FimmCyte Company
FimmCyte develops a novel disease modifying treatments for fibro-inflammatory diseases, starting with Endometriosis.
Connections
Founded Date:
2022-01-01
Employee Number:
1-10
Headquarters:
Basel, Basel-Stadt, Switzerland, Europe
Industry:
Drug Discovery & Development
Super Industry:
Biopharma & Life Science Tools
Investors:
BaseLaunch, BioInnovation Institute, InnoBooster, Innosuisse, Venture Kick
Ipo Status:
private
City:
Basel
Region:
Basel-Stadt
Country:
Switzerland